Investment
Features
FeesSafety
Academy
More
Pluang+

Compare T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance

T-Rex 2X Inverse MSTR Daily Target ETFTrade
Royalty Pharma plc Class A Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

T-Rex 2X Inverse MSTR Daily Target ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? T-Rex 2X Inverse MSTR Daily Target ETF trades at $2.62 (market cap $94.46M), while Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 267.5× T-Rex 2X Inverse MSTR Daily Target ETF's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while T-Rex 2X Inverse MSTR Daily Target ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold T-Rex 2X Inverse MSTR Daily Target ETF for 8 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.

MSTZRPRX
Market Cap
$94.46M$25.27B
Volume
104,717,7333,671,183
Sector
Leveraged / InverseHealth
52-Week High
$27.92$63.96
52-Week Low
$2.29$35.44
Typical Hold Time
8 Days1 Days
Enterprise Value
—$32.50B
Dividend Yield
—1.66%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

T-Rex 2X Inverse MSTR Daily Target ETF

MSTZ trades at $2.58, down 3.01% with bearish technical signals from moving averages. The stock shows mixed momentum with neutral oscillators but negative moving average alignment. Key support sits at $2 with resistance at $3. Recent ETF coverage highlights the stock's inclusion in leveraged/inverse ETF discussions, though specific company fundamentals remain limited in available data.

Outlook remains cautious given technical weakness and limited fundamental visibility. The primary opportunity lies in potential technical rebounds from support levels, while risks include continued bearish momentum and lack of clear fundamental catalysts. Investors should await clearer financial metrics and earnings guidance for directional conviction.

Royalty Pharma plc Class A Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MSTZ
80% Buy20% Sell
Avg holding period · 8 Days
RPRX

No sentiment data available yet.

Top news

Latest headlines on both assets

About T-Rex 2X Inverse MSTR Daily Target ETF

MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.

Read more on MSTZ →

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.

Read more on RPRX →